Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension

通过 IL-6 和 Rac1 独立激活盐皮质激素受体醛固酮可诱导钠潴留和高血压

基本信息

  • 批准号:
    10260469
  • 负责人:
  • 金额:
    $ 16.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Project Abstract The goal of this proposed project titled “Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension” is to investigate the role of renal dendritic cells (rDCs) in mediating cytokine-induced transactivation of the mineralocorticoid receptor (MR), increasing sodium (Na+) reabsorption and blood pressure (BP). Excessive Na+ reabsorption is a main cause of hypertension and end organ damage. The mechanisms mediating pathophysiological Na+ retention are unknown; however, increased inflammation and excessive activation of distal nephron Na+ transporters, the Na+ chloride cotransporter (NCC) and the epithelial Na+ channel (ENaC) play a role. However, the mechanisms linking increased inflammation and cytokines to Na+ transporter activation are yet unidentified. Following a stressor, DCs cells secrete interleukin 6 (IL-6) producing a pro-inflammatory milieu. Our preliminary data suggest that baseline blood pressure (BP) is regulated via rDCs, and the decreased systolic BP levels observed in rDC-depleted mice may be due to decreased NCC protein expression. Further, our data suggest that hypertension (HTN) increases serum IL-6 levels, while renal cortical IL-6 mRNA levels are reduced in rDC-depleted mice. Our robust in vivo data suggest that intrarenal IL-6 infusion increases phosphorylated (pT53) NCC, and total NCC, as well as ENaC expression. We also show that systemic IL-6, plus high salt (HS, 4%) increases BP after 3 days. Together, these data strongly support a role for rDC- mediating local IL-6 levels, and IL-6 increasing Na+ transporter expression and/or activity and BP. Moreover, our in vitro data demonstrates that IL-6 induces MR nuclear translocation and activation of downstream mineralocorticoid response elements (MRE), via the small GTP-ase Rac1 and reactive oxygen species (ROS) generation, and can directly activate thiazide-sensitive Na+ transport. Thus, we hypothesize that intrarenal IL-6 transactivates the MR, increasing distal tubular Na+ reabsorption via NCC and ENaC leading to hypertension. The studies in this proposal, when completed, will demonstrate that: 1) salt-sensitive HTN activates rDCs, 2) rDCs contribute to increased intrarenal IL-6 levels during salt-sensitive HTN, 3) IL-6 independently transactivates the MR and 4) rDC-mediated IL-6 secretion increases NCC and ENaC Na+ transport leading to HTN.
项目摘要 本项目的目标是“醛固酮独立激活盐皮质激素 受体通过IL-6和Rac 1诱导钠潴留和高血压”是为了研究肾脏的作用, 树突状细胞(rDC)介导烟碱诱导的盐皮质激素受体(MR)的反式激活, 增加钠(Na+)重吸收和血压(BP)。过量的Na+重吸收是导致 高血压和终末器官损害。介导病理生理Na+潴留的机制是 然而,炎症增加和远端肾单位Na+转运蛋白过度活化, Na+氯协同转运体(NCC)和上皮Na+通道(ENaC)发挥作用。然而,机制 将增加的炎症和细胞因子与Na+转运蛋白活化联系起来还没有确定。 在应激物之后,DC细胞分泌白细胞介素6(IL-6),产生促炎环境。我们 初步数据表明,基线血压(BP)是通过rDC调节的, 在rDC耗竭小鼠中观察到的BP水平可能是由于NCC蛋白表达降低。此外,我们的数据 提示高血压(HTN)增加血清IL-6水平,而肾皮质IL-6 mRNA水平 在rDC耗尽的小鼠中减少。我们的体内实验数据表明,肾内IL-6输注增加了 磷酸化(pT 53)NCC和总NCC以及ENaC表达。我们还表明,全身IL-6, 加上高盐(HS,4%)3天后血压升高。总之,这些数据有力地支持了RDC的作用- 介导局部IL-6水平,以及IL-6增加Na+转运蛋白表达和/或活性和BP。 此外,我们的体外数据表明,IL-6诱导MR核转位和激活, 下游盐皮质激素反应元件(MRE),通过小GTP酶Rac 1和活性氧 物种(ROS)的产生,并可以直接激活噻嗪敏感的Na+转运。因此,我们假设, 肾内IL-6反式激活MR,通过NCC和ENaC增加远端肾小管Na+重吸收,导致 高血压本提案中的研究完成后,将证明:1)盐敏HTN 激活rDC,2)rDC有助于盐敏感性HTN期间肾内IL-6水平的增加,3)IL-6 rDC介导的IL-6分泌增加NCC和ENaC Na+ 运输到HTN。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brandi Michele Wynne其他文献

Brandi Michele Wynne的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brandi Michele Wynne', 18)}}的其他基金

Funding for Renal/Urothelial Early Career Researchers at the American Physiology Society Summit ETG Sessions
在美国生理学会峰会 ETG 会议上为肾脏/尿路上皮早期职业研究人员提供资助
  • 批准号:
    10683585
  • 财政年份:
    2023
  • 资助金额:
    $ 16.31万
  • 项目类别:
Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension
通过 IL-6 和 Rac1 独立激活盐皮质激素受体醛固酮可诱导钠潴留和高血压
  • 批准号:
    10669391
  • 财政年份:
    2018
  • 资助金额:
    $ 16.31万
  • 项目类别:
Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension
通过 IL-6 和 Rac1 独立激活盐皮质激素受体醛固酮可诱导钠潴留和高血压
  • 批准号:
    10478090
  • 财政年份:
    2018
  • 资助金额:
    $ 16.31万
  • 项目类别:
Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension
通过 IL-6 和 Rac1 独立激活盐皮质激素受体醛固酮可诱导钠潴留和高血压
  • 批准号:
    10016294
  • 财政年份:
    2018
  • 资助金额:
    $ 16.31万
  • 项目类别:
Aldosterone Independent Activation of the Mineralocorticoid Receptor via IL-6 and Rac1 Induces Sodium Retention and Hypertension
通过 IL-6 和 Rac1 独立激活盐皮质激素受体醛固酮可诱导钠潴留和高血压
  • 批准号:
    10505844
  • 财政年份:
    2018
  • 资助金额:
    $ 16.31万
  • 项目类别:

相似海外基金

The study of aldosterone production machinery by angiotensin II metabolite
血管紧张素II代谢物产生醛固酮机制的研究
  • 批准号:
    24890308
  • 财政年份:
    2012
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Aldosterone breakthrough caused by chronic blockage of angiotensin II type-1 receptors in human adrenocortical cells : Involvement of bone morphogenetic protein-6 actions
人肾上腺皮质细胞中血管紧张素 II 1 型受体慢性阻断引起的醛固酮突破:骨形态发生蛋白 6 作用的参与
  • 批准号:
    21790894
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
  • 批准号:
    7604843
  • 财政年份:
    2007
  • 资助金额:
    $ 16.31万
  • 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
  • 批准号:
    7665416
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
Mechanism of aldosterone-induced vascular injury: role of angiotensin II and other factors
醛固酮引起血管损伤的机制:血管紧张素II等因素的作用
  • 批准号:
    18590804
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
  • 批准号:
    7377054
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
  • 批准号:
    7146836
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
  • 批准号:
    7496062
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
  • 批准号:
    7279137
  • 财政年份:
    2006
  • 资助金额:
    $ 16.31万
  • 项目类别:
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
  • 批准号:
    7201385
  • 财政年份:
    2005
  • 资助金额:
    $ 16.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了